Total Payments
$4,249
2024 Payments
$2,190
Companies
34
Transactions
170
Medicare Patients
867
Medicare Billing
$53,928
Payment Breakdown by Category
Food & Beverage$3,169 (74.6%)
Travel$1,080 (25.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,169 | 165 | 74.6% |
| Travel and Lodging | $1,080 | 5 | 25.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,522 | 16 | $0 (2024) |
| Novo Nordisk Inc | $588.53 | 31 | $0 (2024) |
| PFIZER INC. | $247.77 | 11 | $0 (2024) |
| Lilly USA, LLC | $234.06 | 17 | $0 (2024) |
| ABBVIE INC. | $230.05 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $226.37 | 14 | $0 (2024) |
| Abbott Laboratories | $142.02 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122.97 | 8 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $78.92 | 3 | $0 (2022) |
| Noven Therapeutics, LLC | $75.83 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,190 | 54 | Merck Sharp & Dohme LLC ($1,471) |
| 2023 | $1,016 | 52 | Novo Nordisk Inc ($358.87) |
| 2022 | $523.13 | 30 | Biohaven Pharmaceutical Holding Company Ltd. ($78.92) |
| 2021 | $520.49 | 34 | AbbVie Inc. ($120.35) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Biological | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Travel and Lodging | In-kind items and services | $234.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Food and Beverage | In-kind items and services | $56.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Travel and Lodging | In-kind items and services | $401.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Travel and Lodging | In-kind items and services | $234.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Travel and Lodging | In-kind items and services | $148.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Food and Beverage | In-kind items and services | $120.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Biological) | Travel and Lodging | In-kind items and services | $62.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: VACCINE | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Diabetes | ||||||
| 09/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Vaccines | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 491 | 586 | $133,854 | $33,559 |
| 2022 | 7 | 168 | 168 | $37,758 | $10,367 |
| 2021 | 7 | 190 | 190 | $31,327 | $9,949 |
| 2020 | 1 | 18 | 18 | $162.00 | $54.00 |
Total Patients
867
Total Services
962
Medicare Billing
$53,928
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 191 | $63,030 | $14,292 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $24,990 | $7,433 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 73 | $16,206 | $3,665 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 20 | $8,920 | $2,232 | 25.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $7,406 | $1,901 | 25.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $5,632 | $1,497 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 108 | 123 | $1,248 | $1,033 | 82.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 16 | 16 | $4,176 | $1,007 | 24.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 34 | $1,360 | $323.68 | 23.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $676.00 | $103.73 | 15.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 21 | $210.00 | $71.61 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $17,493 | $5,265 | 30.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $6,348 | $1,642 | 25.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 18 | 18 | $4,698 | $1,245 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $4,290 | $1,003 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 17 | $3,774 | $905.98 | 24.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 12 | $732.00 | $166.66 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 47 | 47 | $423.00 | $138.84 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 55 | 55 | $19,635 | $6,029 | 30.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $2,976 | $1,499 | 50.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 21 | $4,662 | $946.40 | 20.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $1,417 | $844.10 | 59.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $1,078 | $230.08 | 21.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $1,001 | $213.86 | 21.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 62 | 62 | $558.00 | $186.00 | 33.3% |
About Ginger Patel, RN, FNP-C
Ginger Patel, RN, FNP-C is a Family healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2016. The National Provider Identifier (NPI) number assigned to this provider is 1033652177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ginger Patel, RN, FNP-C has received a total of $4,249 in payments from pharmaceutical and medical device companies, with $2,190 received in 2024. These payments were reported across 170 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,169).
As a Medicare-enrolled provider, Patel has provided services to 867 Medicare beneficiaries, totaling 962 services with total Medicare billing of $53,928. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Houston, TX
- Active Since 11/21/2016
- Last Updated 11/21/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1033652177
Products in Payments
- LAGEVRIO (Biological) $1,457
- Wegovy (Drug) $286.47
- JARDIANCE (Drug) $250.39
- FARXIGA (Drug) $195.05
- Ozempic (Drug) $158.19
- Rybelsus (Drug) $143.87
- NURTEC ODT (Drug) $132.36
- UBRELVY (Drug) $106.03
- PROCLAIM (Device) $104.34
- VRAYLAR (Drug) $71.83
- PREVNAR 20 (Biological) $70.40
- PAXLOVID (Drug) $63.95
- Xelstrym (Drug) $59.62
- SHINGRIX (Biological) $56.98
- MOUNJARO (Drug) $55.98
- JORNAY PM (Drug) $55.21
- Cologuard Collection Kit (Device) $50.94
- Descovy (Drug) $47.15
- TRINTELLIX (Drug) $45.79
- Dexcom G6 Transmitter (Medical Supply) $42.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Houston
Mrs. Sarah Aguilar, N.p, N.P
Family — Payments: $167,309
Family $167,309
Margaret White, Fnp-Bc, FNP-BC
Family — Payments: $71,272
Family $71,272
Mrs. Katrina King, Arnp, ARNP
Family — Payments: $43,591
Family $43,591
Shaila Khowja, Fnp-C, FNP-C
Family — Payments: $25,332
Family $25,332
Kendrick Clack, Fnp-C, FNP-C
Family — Payments: $22,281
Family $22,281
Tammy Davis
Family — Payments: $18,660
Family $18,660